Navigation Links
diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
Date:9/29/2008

SOUTH SAN FRANCISCO, CALIF., Sept. 29 /PRNewswire/ -- diaDexus, Inc. today announced its partnership with the Living Heart Foundation (LHF), a non-profit organization dedicated to combating cardiovascular disease in current and retired NFL players. The PLAC(R) Test will be included as part of the LHF's cardiovascular risk assessment and disease prevention program designed to identify individuals at elevated risk for suffering a heart attack or stroke.

The PLAC Test is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. The PLAC Test measures lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. It is plaque rupture and thrombosis, not stenosis that cause the majority of cardiac events. Clinical research demonstrates that early diagnosis of cardiovascular disease improves the likelihood of preventing these events.

"Traditional risk factors fail to identify many people at risk for developing cardiovascular disease," said Dr. Archie Roberts, founder of the Living Heart Foundation and a former NFL Quarterback. "We are pleased to offer the PLAC Test which provides new information, beyond traditional risk factors, to help identify those individuals with an increased chance of suffering from a cardiovascular event, allowing them to take the necessary steps to improve not only their health, but also their chance of survival."

Dr. Roberts created the LHF to encourage athletes to educate themselves on the importance of early detection and aggressive management of cardiovascular disease through free health clinics and events. The cardiovascular risk assessment and disease prevention programs held around the country will also contribute to research conducted by the LHF exploring the relationship between professional football players and cardiovascular disease.

'/>"/>
SOURCE diaDexus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Touch Bionics acquires LIVINGSKIN
2. UCB Scholarship Program Awards $300,000 to Students Living with Crohns Disease
3. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
4. ATS Medical Expands Open Pivot Heart Valve Offerings
5. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
6. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
7. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
8. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
9. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
10. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
11. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... This is a professional and ... Papain industry in Global and China. The report ... definitions, applications and industry chain structure. Global market ... with a focus on history, developments, trends and ... the international and Chinese situation is also offered. ...
(Date:8/22/2014)... 2014 Today the Academy of Model Aeronautics ... Court of Appeals for the D.C. Circuit challenging the FAA’s ... the Federal Register on June 25, 2014. , The ... the text and intent of the FAA Modernization and Reform ... prohibition on any new rules or regulations regarding model aircraft ...
(Date:8/22/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the ... 2014 second quarter financial statements and MD&A have been filed on SEDAR ... , Six-months ended June 30, ( in CDN$,000 except per ... 2014 , 2013 Revenue , 2,459 , ... , 56 , 1,485 , 385 ...
(Date:8/22/2014)... Surrey have discovered how the receptors responsible for contractions ... The new study, published today in The FASEB ... turn regulates the cycle of all cells in the ... local biological clock and its control are weakened in ... bladder physiology and ageing. , While currently ...
Breaking Biology Technology:Papain Industry Global & China Development Trend and Proposals Analysis Research Report Available at DeepResearchReports.com 2Papain Industry Global & China Development Trend and Proposals Analysis Research Report Available at DeepResearchReports.com 3AMA Files Petition for Review of FAA’s Interpretive Rule 2Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research 2
... Inc. (Sparta),the maker of TrackWise(R), and the market ... that its TrackWise solution has,been chosen by Protherics ... manufacturing and marketing of specialized products for,critical care ... handling,processes. TrackWise provides organizations with a single, ...
... Oct. 24 Human Genome,Sciences, Inc. (Nasdaq: HGSI ... to discuss its financial results for the quarter ended,September ... on Thursday,November 1, 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ) ... management and will be,held on Thursday, November 1, 2007, ...
... Call on Thursday, October 25, 2007 at ... ... Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ), a biopharmaceutical company focused ... the treatment of life-threatening,diseases, including diabetes and cancer, today announced its ...
Cached Biology Technology:Protherics UK Ltd. Chooses TrackWise for Corrective Action and Preventive Action (CAPA) Management 2Human Genome Sciences To Sponsor Conference Call To Discuss Third Quarter 2007 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 6
(Date:8/22/2014)... 22, 2014 ... announced the addition of the  "Biometrics ... to their offering.       ... a technology that helps in the ... physical or behavioral features. It involves ...
(Date:8/22/2014)... , a leading source of information for businesses and ... California, Riverside in its 2014 list of "some of ... To generate the list, the company analyzed citation data ... work has had enormous impact. , The following UC ... published the greatest number of highly cited papers in ...
(Date:8/22/2014)... CA Research presented at the 29th Annual ... developed by Hera Therapeutics Inc. combats three types ... 70 percent of all cervical cancer. , When ... blocked the replication of HPV-16, HPV-18 and HPV-11 ... Thomas Broker, Ph.D., who presented the findings at ...
Breaking Biology News(10 mins):Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 2Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 35 UC Riverside scientists among world's most influential scientific minds 2
... MADISON Times are tough for wildlife living at the ... Armies are reportedly encamped in a national park and wildlife ... cattle have settled in an adjoining Ugandan park. And ... support more than 900 individuals of the emblematic African lion, ...
... Clinical Research Services (TCRS) at Scottsdale Healthcare and Mayo ... broad potential to treat solid tumors. Clinical ... TGen Clinical Research Services at Scottsdale Healthcare, a partnership ... Scottsdale-based Scottsdale Healthcare Corp., and at Mayo Clinic in ...
... AWRE ), a leading supplier of broadband technology ... the company,s operating results for the fourth quarter and fiscal ... Eastern Time. CEO Michael Tzannes and CFO Rick Moberg will ... Thomson and can be accessed on the Investor Relations page ...
Cached Biology News:Research uncovers surprising lion stronghold in war-torn central Africa 2Research uncovers surprising lion stronghold in war-torn central Africa 3TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug 2Aware Announces Q4 and FY2008 Earnings Conference Call 2
ChIP-GLAS kit for H10K-B microarray chips. Contains ChIP kit, GLAS kit, and hybridization kit. Additional reagents are required. Please see manual for details. Contains sufficient reagent for 20 reac...
...
Highly efficient electroporation solution suitable for transfection of plasmid DNA, oligonucleotides and siRNA. Compatible with all common electroporators....
Removes polysaccharide and phenolic inhibitors of PCR; yields DNA greater than 50 kb in length...
Biology Products: